370 studies found for:    HIV AND (coinfection OR tuberculosis OR TB OR malaria OR hepatitis OR HCV OR HBV OR HPV OR human papillomavirus OR Kaposi's Sarcoma OR KS OR EBV OR Epstein-Barr) | Open Studies
Show Display Options
Rank Status Study
21 Not yet recruiting Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin
22 Unknown  A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients
Conditions: HIV Infections;   Hepatitis B Virus
Intervention:
23 Recruiting HCV/HIV Coinfection: Antiviral Therapy and Fibrosis
Conditions: HIV Infection;   Hepatitis C
Intervention:
24 Recruiting Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Condition: Infections, Papillomavirus
Interventions: Biological: GSK Biologicals' HPV vaccine 580299;   Biological: Merck's Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine (Gardasil)
25 Recruiting Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana
Conditions: Tuberculosis;   HIV
Intervention:
26 Recruiting The Natural History and Treatment of Acute Hepatitis C Virus (HCV) in HIV-positive Individuals
Conditions: Acute Hepatitis C;   HIV
Intervention:
27 Unknown  Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients
Condition: HIV
Intervention: Biological: Sci-B-Vac
28 Not yet recruiting Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .
Conditions: Hepatitis B;   HIV
Intervention: Biological: Recombinant Hepatitis B Virus Vaccine
29 Unknown  HIV-HBV Co-Infection and Liver Disease
Conditions: HIV Infections;   HIV-HBV Co-Infection
Intervention:
30 Unknown  Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients
Conditions: HBV Coinfection;   HIV Infections
Interventions: Drug: raltegravir and tenofovir and lamivudine;   Drug: efavirenz+tenofovir+lamivudine
31 Unknown  Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection
Conditions: HIV;   Hepatitis C;   Liver Fibrosis
Interventions: Drug: Raltegravir;   Drug: Ritonavir-boosted protease inhibitor
32 Recruiting Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV
Conditions: HIV;   Hepatitis B
Interventions: Drug: Tenofovir/lamivudine/lopinavir-ritonavir;   Drug: Zidovudine/lamivudine/lopinavir-ritonavir
33 Recruiting Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients
Conditions: Hepatitis C, Chronic;   Human Immunodeficiency Virus
Intervention: Drug: DAA against HCV
34 Not yet recruiting DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients
Conditions: Human Immunodeficiency Virus;   Acquired Immunodeficiency Syndrome;   Hepatitis C
Intervention: Behavioral: DVD Intervention
35 Recruiting Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Efavirenz (EFV);   Drug: Rifampin-containing anti-TB therapy
36 Recruiting A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes
Conditions: MDR-TB;   HIV
Intervention: Other: NCM-Plus
37 Not yet recruiting CHANGES IN LIVER STEATOSIS AFTER SWITCHING TO RALTEGRAVIR IN HIV/HCV COINFECTION
Conditions: HCV Coinfection;   HIV Infection
Interventions: Drug: Raltegravir;   Drug: Efavirenz
38 Unknown  Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis
Conditions: Tuberculosis;   HIV Infections
Intervention: Drug: Emtricitabine/tenofovir/efavirenz
39 Unknown  Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Raltegravir;   Drug: Atazanavir/Ritonavir
40 Not yet recruiting Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection
Conditions: Hepatitis C, Chronic;   HIV Infection
Interventions: Drug: Raltegravir;   Drug: Efavirenz

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years